Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 138

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review

Liu, Wan-Ting, Chen, En-Zhong, Yang, Ling, Peng, Chen, Wang, Qun, Xu, Zhenbo, Chen, Ding-Qiang·2021·Microbial Pathogenesis
DOI 10.1016/j.micpath.2021.104915
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.micpath.2021.104915

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 89

  1. Jia, 2019, Severe pneumonia caused by coinfection with influenza virus followed by methicillin-resistant Staphylococcus aureus induces higher mortality in mice, Front. Immunol., 9, 10.3389/fimmu.2018.03189 · DOI
  2. Choi, 2010, Antibacterial activity of hylomecon hylomeconoides against methicillin-resistant Staphylococcus aureus, Appl. Biochem. Biotechnol., 160, 2467, 10.1007/s12010-009-8698-5 · doi:10.1007/s12010-009-8698-5
  3. Dadashi, 2018, Methicillin-resistant Staphylococcus aureus (MRSA) in Iran: a systematic review and meta-analysis, Journal of Global Antimicrobial Resistance, 12, 96, 10.1016/j.jgar.2017.09.006 · DOI
  4. Morgenstern, 2016, Antibiotic resistance of commensal Staphylococcus aureus and coagulase-negative staphylococci in an international cohort of surgeons: a prospective point-prevalence study, PloS One, 11, 10.1371/journal.pone.0148437 · DOI
  5. Wassmann, 2018, Molecular mechanisms of thioridazine resistance in Staphylococcus aureus, PloS One, 13, 10.1371/journal.pone.0201767 · DOI
  6. Lin, 2018, Antibacterial mechanism of artemisinin/beta-cyclodextrins against methicillin-resistant Staphylococcus aureus (MRSA), Microb. Pathog., 118, 66, 10.1016/j.micpath.2018.03.014 · DOI
  7. Scudiero, 2020, Human defensins: a novel approach in the fight against skin colonizing Staphylococcus aureus, Antibiotics-Basel., 9
  8. Jenul, 2018, Regulation of Staphylococcus aureus virulence, Microbiol. Spectr., 6
  9. Deyno, 2017, Resistance of Staphylococcus aureus to antimicrobial agents in Ethiopia: a meta-analysis, Antimicrob. Resist. Infect. Contr., 6
  10. Nam, 2019, Antibiotic resistance profile and methicillin-resistant encoding genes of Staphylococcus aureus strains isolated from bloodstream infection patients in northern vietnam, Open access Macedonian journal of medical sciences, 7, 4406, 10.3889/oamjms.2019.871 · doi:10.3889/oamjms.2019.871
  11. Moosavian, 2020, Characterization of SCCmec, spa types and multidrug resistant of methicillin-resistant Staphylococcus aureus isolates in ahvaz, Iran, Infect. Drug Resist., 13, 1033, 10.2147/IDR.S244896 · DOI
  12. Liu, 2016, Staphylococcal chromosomal cassettes mec (SCCmec): a mobile genetic element in methicillin-resistant Staphylococcus aureus, Microb. Pathog., 101, 56, 10.1016/j.micpath.2016.10.028 · DOI · Paper page
  13. Amirkhiz, 2015, SCCmec typing of methicillin-resistant Staphylococcus aureus: an eight year experience, Archives of Pediatric Infectious Diseases, 3
  14. Katayama, 2000, A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 44, 1549, 10.1128/AAC.44.6.1549-1555.2000 · DOI · Paper page
  15. Okwu, 2019, Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: a brief review, Aims Microbiology, 5, 117, 10.3934/microbiol.2019.2.117 · DOI
  16. Foster, 2017, Antibiotic resistance in Staphylococcus aureus. Current status and future prospects, FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Rev., 41, 430
  17. Lee, 2013, Antibacterial activity of a novel flavonoid, 7-O-butyl naringenin, against methicillin-resistant Staphylococcus aureus (MRSA), Food Science and Biotechnology, 22, 1725, 10.1007/s10068-013-0272-9 · doi:10.1007/s10068-013-0272-9
  18. Kot, 2020, Antimicrobial resistance patterns in methicillin-resistant Staphylococcus aureus from patients hospitalized during 2015-2017 in hospitals in Poland, Med. Princ. Pract., 29, 61, 10.1159/000501788 · doi:10.1159/000501788
  19. Crass, 2019, Daptomycin for the treatment of Staphylococcus aureus infections complicated by septic pulmonary emboli, Diagn. Microbiol. Infect. Dis., 93, 131, 10.1016/j.diagmicrobio.2018.09.004 · DOI
  20. Baxi, 2015, Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature, Infection, 43, 751, 10.1007/s15010-015-0763-0 · DOI
  21. Azhar, 2017, Detection of high levels of resistance to linezolid and vancomycin in Staphylococcus aureus, J. Med. Microbiol., 66, 1328, 10.1099/jmm.0.000566 · doi:10.1099/jmm.0.000566
  22. Zhang, 2018, Master mechanisms of Staphylococcus aureus: consider its excellent protective mechanisms hindering vaccine development!, Microbiol. Res., 212, 59, 10.1016/j.micres.2018.05.002 · DOI
  23. 郑波, 2011, 2010年度卫生部全国细菌耐药监测报告:革兰阳性菌耐药监测, 中华医院感染学杂志., 21, 5128
  24. Hu, 2018, Current status and trends of antibacterial resistance in China, Clin. Infect. Dis. : an official publication of the Infectious Diseases Society of America, 67, 10.1093/cid/ciy657 · doi:10.1093/cid/ciy657
  25. 2021, 全国细菌耐药监测网2014—2019年细菌耐药性监测报告, 中国感染控制杂志, 20, 15
  26. Husain, 2018, Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center, J. Lab. Phys., 10, 145
  27. Tian, 2019, Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017), Antimicrob. Resist. Infect. Contr., 8, 86, 10.1186/s13756-019-0545-z · DOI
  28. 2018, 万古霉素和利奈唑胺治疗耐甲氧西林金黄色葡萄球菌所致腹膜透析相关性腹膜炎的疗效和安全性比较, 中国临床医生杂志., 46, 1187
  29. 何翠瑶, 2021, 临床药师参与耐甲氧西林金黄色葡萄球菌骨髓炎伴肾功能亢进患儿的治疗实践, 儿科药学杂志., 27, 45
  30. 杨世界, 2020, 替考拉宁与万古霉素治疗肺癌患者耐甲氧西林金黄色葡萄球菌肺炎的效果观察, 临床医药文献电子杂志., 7, 171+3
  31. Sarkar P, Haldar J. Glycopeptide Antibiotics Mechanism of Action and Recent Developments2020. · DOI
  32. Lin, 2018, Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus, Infect. Drug Resist., 11, 113, 10.2147/IDR.S148335 · doi:10.2147/idr.s148335
  33. Werner, 2008, Acquired vancomycin resistance in clinically relevant pathogens, Future Microbiol., 3, 547, 10.2217/17460913.3.5.547 · DOI
  34. Gomes, 2015, Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus, Pharmacotherapy, 35, 424, 10.1002/phar.1577 · DOI
  35. Chen, 2016, Transcriptional profiling of the two-component regulatory system VraSR in Staphylococcus aureus with low-level vancomycin resistance, Int. J. Antimicrob. Agents, 47, 362, 10.1016/j.ijantimicag.2016.02.003 · DOI
  36. Tan, 2017, Activated ADI pathway: the initiator of intermediate vancomycin resistance in Staphylococcus aureus, Can. J. Microbiol., 63, 260, 10.1139/cjm-2016-0439 · doi:10.1139/cjm-2016-0439
  37. Katayama, 2016, Complete reconstitution of the vancomycin-intermediate Staphylococcus aureus phenotype of strain Mu50 in vancomycin-susceptible S-aureus, Antimicrob. Agents Chemother., 60, 3730, 10.1128/AAC.00420-16 · DOI · Paper page
  38. Yoo, 2013, Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus, J. Microbiol., 51, 160, 10.1007/s12275-013-3088-7 · DOI
  39. Cong, 2020, Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features, J. Adv. Res., 21, 169, 10.1016/j.jare.2019.10.005 · DOI · Paper page
  40. Weigel, 2003, Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus, Science (New York, NY), 302, 1569, 10.1126/science.1090956 · DOI · Paper page
  41. Simjee, 2002, Characterization of Tn1546 in vancomycin-resistant Enterococcus faecium isolated from canine urinary tract infections: evidence of gene exchange between human and animal enterococci, J. Clin. Microbiol., 40, 4659, 10.1128/JCM.40.12.4659-4665.2002 · doi:10.1128/jcm.40.12.4659-4665.2002
  42. Icgen, 2016, VanA-type MRSA (VRSA) emerged in surface waters, Bull. Environ. Contam. Toxicol., 97, 359, 10.1007/s00128-016-1827-2 · DOI
  43. Wu, 2015, Unreported male sex partners among men with newly diagnosed HIV infection - North Carolina, 2011-2013, Mmwr-Morbidity and Mortality Weekly Report, 64, 1037, 10.15585/mmwr.mm6437a2 · DOI
  44. Baltz, 2009, Daptomycin: mechanisms of action and resistance, and biosynthetic engineering, Curr. Opin. Chem. Biol., 13, 144, 10.1016/j.cbpa.2009.02.031 · DOI · Paper page
  45. Mortin, 2007, Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria, Antimicrob. Agents Chemother., 51, 1787, 10.1128/AAC.00738-06 · DOI
  46. Sohlenkamp, 2016, Bacterial membrane lipids: diversity in structures and pathways, FEMS Microbiol. Rev., 40, 133, 10.1093/femsre/fuv008 · DOI · Paper page
  47. Mueller, 2018, Differential daptomycin resistance development in Staphylococcus aureus strains with active and mutated gra regulatory systems, International Journal of Medical Microbiology, 308, 335, 10.1016/j.ijmm.2017.12.002 · DOI · Paper page
  48. Iwata, 2017, Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus, Eur. J. Clin. Microbiol. Infect. Dis., 36, 1839, 10.1007/s10096-017-2999-3 · doi:10.1007/s10096-017-2999-3
  49. Ernst, 2011, Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids, Mol. Microbiol., 80, 290, 10.1111/j.1365-2958.2011.07576.x · DOI · Paper page
  50. Bertsche, 2013, Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates, PloS One, 8, 10.1371/journal.pone.0067398 · DOI
  51. Fukushima, 2011, A role for the essential YycG sensor histidine kinase in sensing cell division, Mol. Microbiol., 79, 503, 10.1111/j.1365-2958.2010.07464.x · DOI
  52. Szurmant, 2007, YycH and YycI interact to regulate the essential YycFG two-component system in Bacillus subtilis, J. Bacteriol., 189, 3280, 10.1128/JB.01936-06 · DOI
  53. Mehta, 2012, VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 56, 92, 10.1128/AAC.00432-10 · DOI · Paper page
  54. Miller, 2016, Mechanism of action and resistance to daptomycin in Staphylococcus aureus and enterococci, Cold Spring Harbor Perspectives in Medicine, 6, 10.1101/cshperspect.a026997 · DOI · Paper page
  55. Muzamal, 2014, Diversity of two-component systems: insights into the signal transduction mechanism by the Staphylococcus aureus two-component system GraSR, F1000Research., 3, 252, 10.12688/f1000research.5512.1 · doi:10.12688/f1000research.5512.1
  56. Howden, 2011, Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR, PLoS Pathog., 7, 10.1371/journal.ppat.1002359 · DOI · Paper page
  57. Baek, 2015, Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene, Antimicrob. Agents Chemother., 59, 6983, 10.1128/AAC.01303-15 · DOI
  58. Peleg, 2012, Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus, PloS One, 7, 10.1371/journal.pone.0028316 · DOI · Paper page
  59. Otero, 2013, How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function, Proc. Natl. Acad. Sci. U.S.A., 110, 16808, 10.1073/pnas.1300118110 · DOI · Paper page
  60. Rolston, 2019, Bactericidal activity of ceftaroline, vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolates from cancer patients, Journal of Global Antimicrobial Resistance, 17, 16, 10.1016/j.jgar.2019.02.018 · doi:10.1016/j.jgar.2019.02.018
  61. Haseeb, 2019, Addition of ceftaroline fosamil or vancomycin to PMMA: an in vitro comparison of biomechanical properties and anti-MRSA efficacy, J. Orthop. Surg., 27, 10.1177/2309499019850324 · doi:10.1177/2309499019850324
  62. Kelley, 2015, Missense mutations in PBP2A affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in western Switzerland archived since 1998, Antimicrob. Agents Chemother., 59, 1922, 10.1128/AAC.04068-14 · DOI
  63. Lee, 2018, Ceftaroline resistance by clone-specific polymorphism in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 62, 10.1128/AAC.00485-18 · DOI · Paper page
  64. Bongiorno, 2019, Genotypic analysis of Italian MRSA strains exhibiting low-level ceftaroline and ceftobiprole resistance, Diagn. Microbiol. Infect. Dis., 95, 114852, 10.1016/j.diagmicrobio.2019.06.004 · doi:10.1016/j.diagmicrobio.2019.06.004
  65. Lahiri, 2015, Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline, J. Antimicrob. Chemother., 70, 2488, 10.1093/jac/dkv131 · DOI
  66. Chan, 2016, PBP 4 mediates high-level resistance to new-generation cephalosporins in Staphylococcus aureus, Antimicrob. Agents Chemother., 60, 3934, 10.1128/AAC.00358-16 · DOI
  67. Hamilton, 2017, High-level resistance of Staphylococcus aureus to beta-lactam antibiotics mediated by penicillin-binding protein 4 (PBP4), Antimicrob. Agents Chemother., 61
  68. Gostev, 2019, In vitro ceftaroline resistance selection of methicillin-resistant Staphylococcus aureus involves different genetic pathways, Microb. Drug Resist., 25, 1401, 10.1089/mdr.2019.0130 · DOI
  69. Andrey, 2017, Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals, Eur. J. Clin. Microbiol. Infect. Dis., 36, 343, 10.1007/s10096-016-2807-5 · doi:10.1007/s10096-016-2807-5
  70. Lahiri, 2016, Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline, J. Antimicrob. Chemother., 71, 34, 10.1093/jac/dkv329 · doi:10.1093/jac/dkv329
  71. Alm, 2014, Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective, J. Antimicrob. Chemother., 69, 2065, 10.1093/jac/dku114 · DOI
  72. Greninger, 2016, Whole-genome sequencing of methicillin-resistant Staphylococcus aureus resistant to fifth-generation cephalosporins reveals potential non-mecA mechanisms of resistance, PloS One, 11, 10.1371/journal.pone.0149541 · DOI · Paper page
  73. Jousselin, 2016, The Staphylococcus aureus chaperone PrsA is a new auxiliary factor of oxacillin resistance affecting penicillin-binding protein 2A, Antimicrob. Agents Chemother., 60, 1656, 10.1128/AAC.02333-15 · DOI
  74. Brickner, 2008, Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections, J. Med. Chem., 51, 1981, 10.1021/jm800038g · DOI · Paper page
  75. Sadowy, 2018, Linezolid resistance genes and genetic elements enhancing their dissemination in enterococci and streptococci, Plasmid, 99, 89, 10.1016/j.plasmid.2018.09.011 · DOI
  76. Lesher, 2016, Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic, Clin. Outcomes Res., 8, 63, 10.2147/CEOR.S91985 · doi:10.2147/ceor.s91985
  77. Swaney, 1998, The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria, Antimicrob. Agents Chemother., 42, 3251, 10.1128/AAC.42.12.3251 · DOI · Paper page
  78. Long, 2012, Resistance to linezolid caused by modifications at its binding site on the ribosome, Antimicrob. Agents Chemother., 56, 603, 10.1128/AAC.05702-11 · DOI · Paper page
  79. Endimiani, 2011, Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in cleveland, Ohio. Antimicrobial Agents and Chemotherapy, 55, 1684, 10.1128/AAC.01308-10 · DOI
  80. Besier, 2008, Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances, Antimicrob. Agents Chemother., 52, 1570, 10.1128/AAC.01098-07 · DOI
  81. Yoo, 2020, Linezolid resistance in methicillin-resistant Staphylococcus aureus in korea: high rate of false resistance to linezolid by the VITEK 2 system, Annals of Laboratory Medicine, 40, 57, 10.3343/alm.2020.40.1.57 · DOI
  82. Locke, 2010, Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with Co-occurring mutations in ribosomal protein L3, Antimicrob. Agents Chemother., 54, 5352, 10.1128/AAC.00714-10 · DOI
  83. Locke, 2009, Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700), Antimicrob. Agents Chemother., 53, 5265, 10.1128/AAC.00871-09 · DOI · Paper page
  84. Ruiz-Ripa, 2020, Mechanisms of linezolid resistance among clinical Staphylococcus spp. in Spain: spread of methicillin- and linezolid-resistant S. Epidermidis ST2, Microb. Drug Resist.
  85. Hashemian, 2018, Linezolid: a review of its properties, function, and use in critical care, Drug Des. Dev. Ther., 12, 1759, 10.2147/DDDT.S164515 · DOI · Paper page
  86. Li, 2018, Characterization of the multi-drug resistance gene cfr in methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from animals and humans in China, Front. Microbiol., 9, 10.3389/fmicb.2018.02925 · DOI
  87. Zhou, 2018, Increased activity of linezolid in combination with rifampicin in a murine pneumonia model due to MRSA, J. Antimicrob. Chemother., 73, 1899, 10.1093/jac/dky129 · DOI
  88. Zhou, 2020, Linezolid and rifampicin combination to combat cfr-positive multidrug-resistant MRSA in murine models of bacteremia and skin and skin structure infection, Front. Microbiol., 10, 10.3389/fmicb.2019.03080 · DOI
  89. Lazaris, 2017, Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE, J. Antimicrob. Chemother., 72, 3252, 10.1093/jac/dkx292 · DOI

Cited by

See all 138

Metadata

Authors
Liu, W.-T., Chen, E.-Z., Yang, L., Peng, C., Wang, Q., Xu, Z., & Chen, D.-Q.
ORCID
Xu, Zhenbo
Venue
Microbial Pathogenesis
Publisher
Elsevier BV
Published
2021-07
Volume
156
Pages
104915
ISSN
0882-4010
DOI
10.1016/j.micpath.2021.104915
Cited by
138
References
1
Language
en
Licence
Funders
National Natural Science Foundation of China

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review. https://app.cochat.ai/papers/10.1016/j.micpath.2021.104915
The paper
Liu, W.-T., Chen, E.-Z., Yang, L., Peng, C., Wang, Q., Xu, Z., & Chen, D.-Q. (2021). Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2021.104915

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.